Basic Information
Insulatard
Regulatory Information
EMEA/H/C/000441
Authorised
October 7, 2002
20
November 23, 2020
Company Information
Denmark
Novo Allé DK-2880 Bagsvaerd
Novo Nordisk A/S
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Treatment of diabetes mellitus.
Overview Summary
This is a summary of the European public assessment report (EPAR) for Insulatard. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Insulatard.